| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bcec30486412ec5bcc7d9e283309ae63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24b0f980819ebb03908c104cf51329f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9fb7bbc09927d64558e1e99a3b7c719b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a650e818b2e51621d82d93e28cf29afe |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-627
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-585 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-012
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6849
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6811
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4703
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-01 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12 |
| filingDate |
2015-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19b590a50299817eed3c75911ef6e6d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfd4f4645533abf77726f621f91ad7ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc7834bea691e7f52ac35646aad8ea97 |
| publicationDate |
2015-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2015179434-A1 |
| titleOfInvention |
Small molecule ras inhibitors |
| abstract |
Disclosed herein are novel compounds that are Ras inhibitors. Also disclosed are compositions comprising the compounds and methods of using the compounds in treating various diseases. In another aspect, provided is an antibody-drug-conjugate comprising an antibody conjugated with a compound described herein. In still another aspect, provided is a pharmaceutical composition comprising a compound or antibody-drug-conjugate described herein. In a further aspect, provided is method of treating a cancer comprising administering a therapeutically effective amount of a compound or antibody-drug-conjugate described herein to a patient in need thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4218784-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11732002-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023113739-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021245219-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11492369-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3790890-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11787836-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11542299-B2 |
| priorityDate |
2014-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |